H-CYTE: INNOVEREN SCIENTIFIC INC.: Innoveren Scientific Divests Device & Receives Capital Infusion
Proceeds to be used to complete corporate rebranding, accelerate acquisition pipeline, and attract additional investmentTAMPA, FL / ACCESSWIRE / October 3, 2023 / Innoveren Scientific Inc. (OTCQB:I...
Read full article »
CEO
Michael Yurkowsky
H-CYTE is a biotech company that develops and commercializes therapies for the treatment for lung diseases.
Read more